880150 | 14:0 PEG2000 PE

1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt)


Powder

Size SKU Packaging Price
25mg 880150P-25mg 880150P-25mg 1 x 25mg $153.75
200mg 880150P-200mg 880150P-200mg 1 x 200mg $328.00
500mg 880150P-500mg 880150P-500mg 1 x 500mg $695.00
1g 880150P-1g 880150P-1g 1 x 1g $1,198.80
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
(Sales Tax may apply)
Please select an option above.
${sku} - ${concentration}

14:0 PEG2000 PE

14:0 PEG2000 PE

1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt)

Representative Structure

The molecular weight and exact mass are averages based on the polydispersity of PEG.

Hygroscopic
Yes
Light Sensitive
No
Molecular Formula

C125H251N2O55P (average MW due to polydispersity of PEG)

Percent Composition

C 55.74%, H 9.39%, N 1.04%, O 32.67%, P 1.15%

Purity
>99%
Stability
1 Years
Storage Temperature
-20°C
CAS Number
474922-82-2
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
2693.320
Exact Mass
2691.660
Synonyms
1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[carbonyl-methoxy(polyethylene glycol)-2000] (ammonium salt)

Lou G, Anderluzzi G, Tandrup Schmidt S, Woods S, Gallorini S, Brazzoli M, Giusti F, Ferlenghi I, Johnson R, Roberts CW, O'Hagan DT, Baudner BC, Perrie Y. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection. J Control Release. 2020 Jun 30:S0168-3659(20)30362-X. doi: 10.1016/j.jconrel.2020.06.027. Epub ahead of print. PMID: 32619745.

PubMed ID: 32619745

Leboeuf D, Abakumova T, Prikazchikova T, Rhym L, Anderson DG, Zatsepin TS, Piatkov KI. Downregulation of the Arg/N-degron Pathway Sensitizes Cancer Cells to Chemotherapy In Vivo. Mol Ther. 2020 Jan 21:S1525-0016(20)30053-8. doi: 10.1016/j.ymthe.2020.01.021. Epub ahead of print. PMID: 32087767.

PubMed ID: 32087767

Lone A, Thomsen TT, Nielsen JE, Thulstrup PW, Klitgaard RN, Løbner-Olesen A, Lund R, Jenssen H, Hansen PR. Structure-Activity Study of an All-d Antimicrobial Octapeptide D2D. Molecules. 2019 Dec 13;24(24):4571. doi: 10.3390/molecules24244571. PMID: 31847173; PMCID: PMC6943423.

PubMed ID: 31847173

Chen X, Mangala LS, Mooberry L, Bayraktar E, Dasari SK, Ma S, Ivan C, Court KA, Rodriguez-Aguayo C, Bayraktar R, Raut S, Sabnis N, Kong X, Yang X, Lopez-Berestein G, Lacko AG, Sood AK. Identifying and targeting angiogenesis-related microRNAs in ovarian cancer. Oncogene. 2019 Aug;38(33):6095-6108. doi: 10.1038/s41388-019-0862-y. Epub 2019 Jul 9.

PubMed ID: 31289363

Nielsen JE, Lind TK, Lone A, Gerelli Y, Hansen PR, Jenssen H, Cárdenas M, Lund R. A biophysical study of the interactions between the antimicrobial peptide indolicidin and lipid model systems. Biochim Biophys Acta Biomembr. 2019 Apr 9;1861(7):1355-1364. doi: 10.1016/j.bbamem.2019.04.003. [Epub ahead of print]

PubMed ID: 30978313

Callegari E, Domenicali M, Shankaraiah RC, D'Abundo L, Guerriero P, Giannone F, Baldassarre M, Bassi C, Elamin BK, Zagatti B, Ferracin M, Fornari F, Altavilla G, Blandamura S, Silini EM, Gramantieri L, Sabbioni S, Negrini M. MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer. Mol Ther Nucleic Acids. 2019 Mar 1;14:239-250. doi: 10.1016/j.omtn.2018.11.018. Epub 2018 Dec 6.

PubMed ID: 30641476